Literature DB >> 25326470

Importance of primary percutaneous coronary intervention for reducing mortality in ST-elevation myocardial infarction complicated by out of hospital cardiac arrest.

F A Choudry1, R P Weerackody2, A D Timmis2, A Wragg2, A Mathur1, S Sporton3, P G Mills2, A K Jain4.   

Abstract

BACKGROUND: Current recommendations are for primary percutaneous coronary intervention (pPCI) in ST-elevation myocardial infarction (STEMI) complicated by out of hospital cardiac arrest (OHCA). However, information about longer-term outcomes is sparse, particularly among high-risk patients who do not regain consciousness promptly after resuscitation. METHODS AND
RESULTS: Of 1836 consecutive patients admitted with STEMI for pPCI between April 2008-October 2011, 132 (7.2%) who had suffered OHCA with recovery of spontaneous circulation (ROSC) form the study population. 101 patients survived to hospital discharge (76.5%) with only one further death in the first year. Prognosis was worse for the 62 patients who were unconscious on arrival and required admission to the intensive therapy unit (ITU), only 54% of whom survived. Every additional minute in the time to ROSC increased the hazard of death by 1.7% while alertness upon ROSC and successful reperfusion in response to pPCI reduced the hazard of death by 90% and 65% respectively. Full neurological recovery was recorded in 85.1% of those who survived to be discharged but in only 30.6% of the 34 survivors who were admitted unconscious and received ITU treatment. Every additional minute in the time to ROSC increased the odds of neurological deficit by 7.0%.
CONCLUSIONS: In patients with STEMI who are conscious after OHCA, high rates of survival can be achieved with pPCI, depending in part on the time it takes for ROSC. Prognosis is less good in the subgroup brought to hospital unconscious but even in this high risk group neurologically intact survival can be achieved in about one-third of cases, suggesting the benefit of immediate pPCI in STEMI patients successfully resuscitated after OHCA. © The European Society of Cardiology 2014.

Entities:  

Keywords:  ST-elevation myocardial infarction; out of hospital cardiac arrest; primary percutaneous coronary intervention

Mesh:

Year:  2014        PMID: 25326470     DOI: 10.1177/2048872614555990

Source DB:  PubMed          Journal:  Eur Heart J Acute Cardiovasc Care        ISSN: 2048-8726


  5 in total

1.  Cardiac arrest secondary to acute coronary syndrome: a 4-year observational study of patient characteristics and outcomes.

Authors:  M Gorecka; A Hanley; F Burke; P Nolan; J Crowley
Journal:  Ir J Med Sci       Date:  2016-02-19       Impact factor: 1.568

Review 2.  Formal consensus to identify clinically important changes in management resulting from the use of cardiovascular magnetic resonance (CMR) in patients who activate the primary percutaneous coronary intervention (PPCI) pathway.

Authors:  Maria Pufulete; Rachel C Brierley; Chiara Bucciarelli-Ducci; John P Greenwood; Stephen Dorman; Richard A Anderson; Jessica Harris; Elisa McAlindon; Chris A Rogers; Barnaby C Reeves
Journal:  BMJ Open       Date:  2017-06-22       Impact factor: 2.692

3.  Both baseline Selvester QRS score and change in QRS score predict prognosis in patients with acute ST-segment elevation myocardial infarction after percutaneous coronary intervention.

Authors:  Qian Liu; Yong Zhang; Pengqiang Zhang; Junbo Zhang; Xiaojiao Cao; Shanshan He; Donghui Yang
Journal:  Coron Artery Dis       Date:  2020-08       Impact factor: 1.717

4.  A service evaluation of transport destination and outcome of patients with post-ROSC STEMI in an English ambulance service.

Authors:  Anthony Platt
Journal:  Br Paramed J       Date:  2020-06-01

5.  Predictors of Mortality in Patients with ST-Segment Elevation Acute Myocardial Infarction and Resuscitated Out-of-Hospital Cardiac Arrest.

Authors:  Andreea Bărcan; Monica Chițu; Edvin Benedek; Nora Rat; Szilamer Korodi; Mirabela Morariu; Istvan Kovacs
Journal:  J Crit Care Med (Targu Mures)       Date:  2016-02-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.